Try our mobile app

Strategic review of Advanced Health

Published: 2022-06-15 09:00:00 ET
<<<  go to JSE:AVL company page
Advanced Health Limited (JSE:AVL) News - Strategic review of Advanced Health

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049        JSE Code: AVL


STRATEGIC REVIEW OF ADVANCED HEALTH


Shareholders are advised that the Advanced Health board of directors has appointed an internal sub-
committee to conduct a strategic review of the Advanced Health group to assess options available to
maximise shareholder value in Advanced Health. This process will involve an assessment of Advanced
Health’s strategic options and the alternative strategies available to unlock and enhance value for Advanced
Health shareholders.

There are no assurances that the board will decide to pursue, nor that any transaction or transactions will
result from, this strategic review. Shareholders do not need to take any action in relation to the strategic
review. Advanced Health will continue to keep shareholders informed about the progress and outcomes of
the strategic review.

Pretoria
15 June 2022

Designated Advisor
Grindrod Bank Limited

Date: 15-06-2022 11:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.